fashion -WSS

fashion

author：hotspot 2025-10-02 00:43:25 - browse：493

Exterior photo of UnitedHealth Group building — UnitedHealth Group is attempting to buy Amedisys for $3.3 billion. Courtesy UnitedHealth Group

There’s now a two-party showdown for one of the largest home health companies in the country.

UnitedHealth Group and its Optum division on Monday formally proposed to buy Amedisys for $100 per share, or about $3.3 billion.

The offer comes a few weeks after Option Care Health proposed a $3.6 billion takeover. However, Option Care’s deal is an all-stock transaction, whereas UnitedHealth would pay all cash — a potentially more attractive offer for Amedisys shareholders who want a more immediate payout that isn’t tied to the unpredictability of another company’s stock price. Option Care’s offer is technically worth closer to $2.8 billion now, due to the drop in Option Care’s stock price since the merger was announced. Amedisys is recommending shareholders vote in favor of the deal with Option Care.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Alkermes shareholders re
Next article： Study: Lilly Alzheimer's therapy slowed patients' cognitive decline

explore

WSS

What is the Wagner Group? The 'brutal' Russian military unit in Ukraine

CDC concerned about possible undetected monkeypox spread in U.K.

Experimental asthma app from Apple and Anthem shows promise

Today's health inequities arise from racist U.S. history, say experts

In areas with more Black doctors, Black people live longer

Ask STAT: What do you want to know about ChatGPT in medicine?

hotspot

fashion

focus

23andMe had bad news about my health. I wish a person had delivered it

First transplant of an entire human eye performed

Affirmative action in medical school literally saved lives

CDC concerned about possible undetected monkeypox spread in U.K.

Guidelines to prevent youth baseball injuries need more muscle

The battle over the Brookhaven Landfill on Long Island

State Dept. review finds Biden bears some blame for Afghanistan failures

Healthy food access boosts outcomes in two studies

After affirmative action ruling, medical educators look to 'holistic review'

Weight bias in eating disorder treatment complicated by new weight loss drugs

focus

Ventyx halts psoriasis drug development after lackluster trial results

A letter from the executive editor: STAT UnitedHealth investigation

STAT's guide to the next generation of CAR

Ohio still needs to do more to protect the right to abortion

Medical school prerequisites are outdated

Weight bias in eating disorder treatment complicated by new weight loss drugs

hotspot

knowledge

explore

hotspot